Coats PLC, a leading global industrial thread and footwear component manufacturer, has reported robust financial results for the six months ending June 30, 2026. The company successfully sustained its adjusted earnings before interest and tax (EBIT margin) at 19.8 percent, demonstrating effective cost management and procurement strategies despite a challenging market environment.
During this period, Coats PLC achieved group revenue of $837 million. This represents a 1 percent increase on an organic constant exchange rate (CER) basis compared to the previous year, highlighting consistent revenue growth. Adjusted basic earnings per share stood at 4.4 cents, a slight adjustment from 4.7 cents in the first half of 2025. Free cash flow for the period reached $30 million, compared to $38 million a year earlier, a figure the company noted reflects typical seasonal weighting towards the latter half of the year. The firm also confirmed that its leverage remains on track to reach 2.0x or below by the close of 2026.
“We are pleased with our first-half outperformance relative to the market and confident in our second-half outlook, despite the prolonged period of industry de-stocking,” stated David Paja, Group Chief Executive of Coats PLC. “We continue to prove the resilience of our business model by maintaining margins and generating good free cash flow during periods of adverse market conditions.” The company’s focus on strategic initiatives has clearly bolstered its Coats H1 2026 Financials.
Segment Performance Highlights
The Apparel segment delivered a 1 percent organic growth, a performance largely attributed to portfolio-wide share gains and strong demand emanating from China’s domestic and automotive thread markets. This sector’s performance was a key driver in the overall revenue growth.
The Footwear division saw flat organic revenue; however, it experienced notable acceleration in the second quarter and strong growth from composite tapes tailored for energy markets. Conversely, OrthoLite revenue experienced a year-on-year decline. This was influenced by a strong comparative period in the prior year and temporary capacity challenges encountered in Indonesia, which are actively being addressed. Despite this, OrthoLite contributed positively to the maintained EBIT margin.
Strategic Outlook and Future Initiatives
Coats PLC has reaffirmed its full-year and medium-term outlook. The company anticipates continued market outperformance and expects growth to be driven by ongoing share gains, secured pricing strategies, targeted adjacencies, and the launch of new products. Despite projecting modest market declines in the second half of the year, incremental cost actions are forecast to deliver approximately $15 million in benefits, including synergies from OrthoLite.
A strong free cash flow is projected for the full year, aligning with the group’s ambitious $1 billion cumulative target over the next five years. Ongoing investments in innovation and enhanced capabilities are set to fuel accelerated growth in the medium term. These forward-looking strategies underpin the positive outlook for future financial results.
Mr. Paja further commented, “We remain very excited by the enhanced capabilities and deeper customer relationships that OrthoLite has brought to the group and we see substantial incremental value creation potential from sales synergies. Against this backdrop, we reaffirm our confidence to deliver FY results in line with market expectations.” The solid Coats H1 2026 Financials lay a strong foundation for these future endeavors.
